Rosas Samuel, Luo T David, Jinnah Alexander H, Marquez-Lara Alejandro, Roche Martin W, Emory Cynthia L
Department of Orthopedic Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Department of Orthopedic Surgery, Holy Cross Orthopedic Institute, Fort Lauderdale, Florida.
J Knee Surg. 2019 Apr;32(4):337-343. doi: 10.1055/s-0038-1641155. Epub 2018 Apr 4.
Risk factors for adverse events after total knee arthroplasty (TKA) relating to malignancy have not been well studied. Thus, the purpose of this study was to conduct a retrospective case-control outcome and cost analysis after TKA in this population. Patients with a history of breast cancer (BrCa) were identified based on the International Classification of Disease 9th revision codes. An age- and sex-matched cohort was also identified of patients without a history of BrCa. Complications, length of stay, comorbidity burden, and reimbursements were tracked at 90 days. Each cohort comprised 92,557 patients. Length of stay was similar between cohorts ( = 0.627). Comorbidity status and incidence of pulmonary embolism (PE), lower extremity ultrasound, and chest computed tomography (CT) use were higher in patients with a history of BrCa ( < 0.05 for all). Control patients had a lower incidence of acute myocardial infarction (0.14 vs. 0.21%; < 0.001). Surgical complications were similar. The 90-day reimbursements were greater in patients with a history of BrCa (US$13,990 vs. US$13,033 for controls; = 0.021). Surgeons should be aware of the increased risk of PE after TKA in patients with a history of BrCa as well as increased 90-day costs, which warrant great attention.
全膝关节置换术(TKA)后与恶性肿瘤相关的不良事件风险因素尚未得到充分研究。因此,本研究的目的是对该人群TKA术后进行回顾性病例对照结局和成本分析。根据国际疾病分类第9版编码确定有乳腺癌(BrCa)病史的患者。还确定了一个年龄和性别匹配的无BrCa病史患者队列。在90天时跟踪并发症、住院时间、合并症负担和报销情况。每个队列包括92557名患者。队列之间的住院时间相似(=0.627)。有BrCa病史的患者合并症状态以及肺栓塞(PE)发生率、下肢超声和胸部计算机断层扫描(CT)的使用更高(所有P<0.05)。对照患者急性心肌梗死的发生率较低(0.14%对0.21%;P<0.001)。手术并发症相似。有BrCa病史的患者90天报销费用更高(BrCa患者为13990美元,对照患者为13033美元;P=0.021)。外科医生应意识到有BrCa病史的患者TKA术后PE风险增加以及90天成本增加,这值得高度关注。